Moleculin Biotech, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2016 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Moleculin Biotech, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2016 to Q2 2024.
  • Moleculin Biotech, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 1, 2024 was 2.56M shares, a 91.4% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 2.56M -27.2M -91.4% Aug 1, 2024 10-Q 2024-08-13
Q1 2024 2.23M -26.4M -92.2% Mar 14, 2024 10-K/A 2024-04-26
Q3 2023 29.8M +1.18M +4.13% Nov 1, 2023 10-Q 2023-11-13
Q2 2023 29.8M +1.2M +4.21% Aug 1, 2023 10-Q 2023-08-10
Q1 2023 28.6M +49.5K +0.17% Mar 14, 2023 10-K 2023-03-22
Q3 2022 28.6M +50.7K +0.18% Nov 3, 2022 10-Q 2022-11-10
Q2 2022 28.6M +54.5K +0.19% Aug 1, 2022 10-Q 2022-08-12
Q1 2022 28.6M +134K +0.47% Mar 14, 2022 10-K 2022-03-24
Q3 2021 28.6M -33.9M -54.3% Nov 3, 2021 10-Q 2021-11-10
Q2 2021 28.6M -33.2M -53.7% Aug 3, 2021 10-Q 2021-08-11
Q1 2021 28.4M -24.8M -46.6% Mar 11, 2021 10-K 2021-03-24
Q3 2020 62.5M +16.7M +36.6% Nov 5, 2020 10-Q 2020-11-12
Q2 2020 61.7M +16.5M +36.5% Aug 7, 2020 10-Q 2020-08-12
Q1 2020 53.2M +8.04M +17.8% Mar 10, 2020 10-K 2020-03-19
Q3 2019 45.7M +18.6M +68.6% Nov 8, 2019 10-Q 2019-11-12
Q2 2019 45.2M +18.3M +68.3% Aug 8, 2019 10-Q 2019-08-16
Q1 2019 45.2M +19.4M +75.4% May 10, 2019 10-Q 2019-05-13
Q4 2018 28.5M Feb 1, 2019 10-K 2019-02-21
Q3 2018 27.1M +5.99M +28.4% Nov 9, 2018 10-Q 2018-11-13
Q2 2018 26.9M +6.6M +32.6% Aug 1, 2018 10-Q 2018-08-10
Q1 2018 25.8M +8.59M +50% Mar 16, 2018 10-K 2018-03-28
Q3 2017 21.1M +9.08M +75.3% Nov 1, 2017 10-Q 2017-11-13
Q2 2017 20.3M +9.03M +80.5% Aug 1, 2017 10-Q 2017-08-11
Q1 2017 17.2M Mar 24, 2017 10-K 2017-04-03
Q3 2016 12.1M Nov 9, 2016 10-Q 2016-11-21
Q2 2016 11.2M Jun 13, 2016 10-Q 2016-06-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.